Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathwayNavid Koleini(Johns Hopkins University), Elissavet Kardami(University of Manitoba)OncotargetAugust 24, 201710.18632/oncotarget.20558Cited by 30SaveCiteExport RISWatch citationsRelated PapersDepressed Proximal Glycolysis in Myocardium Of Human Heart Failure with Preserved Ejection Fraction|medRxiv|2023|0